Our mission, since 2018, is to advance Leukemia medical research using the latest technologies such as Artificial Intelligence (Computer Vision & Natural Language Understanding/Processing), Internet of Things, Robotics, Virtual/Augmented/Mixed Reality, 3D Design & Printing and Blockchain. We aim to ensure our research, findings, and technologies remain free to anyone that can benefit from their use, whether personal, educational or commercial.
The Peter Moss Leukemia AI Research Student Program provides college & university students with real world projects & experience in working with AI for medical purposes, helping further their education and understanding.
Our students communicate with our team remotely as our student program is an online initiative, Research Interns can participate from anywhere in the world.
We are creating an open source movement for leukemia & medical technology research. No patents, no proprietary data, no proprietary code. We want to change how the medical system works, and provide our research and technology open and free.
The Covid-19 AI Research Project is an Asociacion De Investigacion En Inteligencia Artificial Para La Leucemia Peter Moss research project, with the goal of creating open source technology such as Robotics, Artificial Intelligence, Virtual Reality and Internet of Things to assist in the fight against the COVID-19 (SARS-CoV-2) pandemic.
Since our first research project began, we have been dedicated to finding sharing open information with our community. The Leukemia AI Research Information Database is a collection of open information related to Leukemia, other bone marrow cancers and blood diseases.
The Leukemia AI Research Events area is where you will find profiles for events we have organised, spoke at, or visited. The profiles provide information, photos, videos and links for events related to medical technologies, particularly artificial intelligence for medical use.
We are a group of volunteers dedicated to the fight against Leukemia & COVID-19 using the latest technologies. We have experience in modern technologies including Artificial Intelligence (Computer Vision & Natural Language Understanding/Processing), Internet of Things, Engineering, Robotics, Virtual/Augmented/Mixed Reality, 3D Design & Printing, Blockchain, Industrial design, Sociobiology, Animatronics, Zoology, Etho robotics, HRI, Biomimicry, Flexible Mechanical Metamaterial, Immunology and Bioinfomatics.
Since 2018 we have been volunteering our spare time to researching into how artificial intelligence can be used for early detection, drug discovery, and conversational support agents for battling Leukemia, and now COVID-19. We are also actively involved in open-source robotics, virtual reality, online systems and private networks for medical and health organizations.
The Peter Moss Acute Lymphoblastic Leukemia Detection System 2019 is a featured project on Intel Devmesh, the Intel Developer Zone social network.
The project is an open source detection system that allows you to upload Acute Lymphoblastic Leukemia data and run classifications to detect positive and negative examples using Intel technologies.
The project was voted 1st in Europe out of 4 projects, and awarded the Intel® DevMesh AI Spotlight Award which was a new designation granted by Intel recognizing inspiring and breakthrough Artificial Intelligence projects in development from the Intel software community.